Current treatment regimens of obesity include dietary and lifestyle interventions, bariatric surgeries, and few pharmacological drugs such as glucagon-like peptide-1 (GLP-1) agonists [5,6]. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.